TCG Partner Charlie Turner Advises Client, Asklepios BioPharmaceutical, Inc., in Execution of License with AveXis, Inc., for Use of Duplex Vector Technology in SMA Gene Therapy Program
Click “Read more” and then click on the link for the press release: